Few Differences Found in Outcomes With Various Venous Thromboembolism Prophylaxis Protocols
Researchers found that most instances of venous thromboembolism occurred while patients were receiving prophylaxis.
Diagnosis & Disease Information
Measurable Residual Disease: The Future of Multiple Myeloma Assessment?
Advances in technology for detecting measurable residual disease (MRD) are also raising questions regarding the role of MRD in managing multiple myeloma.
Expert Panel Releases Recommendations on Unmet Clinical Needs With Ph-Negative Myeloproliferative Neoplasms
An overview of the findings of an expert panel that examined the unmet clinical needs for patients with Ph-negative MPNs to assess for risks of thrombosis.
VTE Risk May be Higher in Patients Who Receive Chemotherapy
Risk of venous thromboembolism (VTE) may be higher in patients with cancer who receive chemotherapy.
Dalteparin Thromboprophylaxis Associated With Reduced Risk of VTE in Cancer
Thromboprophylaxis with dalteparin is associated with a non-significant decreased risk of venous thromboembolism (VTE).
Tinzaparin May Not Lower Risk of Recurrent VTE in Active Cancer
Among patients with active cancer, full-dose tinzaparin daily compared with warfarin did not significantly reduce the composite measure of recurrent VTE.
Occult Cancers Rare in Unprovoked Venous Thromboembolism
Prevalence of occult cancer is low among patients with first unprovoked venous thromboebolism (VTE).
Inferior Vena Cava Filters in Patients with Cancer
The placement of an inferior vena cava filter is understudied in patients with cancer and clear guidelines do not exist.
Anticoagulation May Be Safe for Patients with Brain Metastases
Therapeutic anticoagulation is safe for treating venous thromboembolism in patients with cancer that has metastasized to the brain.
Enoxaparin Efficacious, Feasible for Prevention of VTE in Advanced Pancreatic Cancer
Recent research shows that enoxaparin effectively prevents VTE complications in advanced pancreatic cancer without decreasing efficacy of chemotherapy.
- Loading...
Loading...
Next post in Pancreatic Cancer
Loading... 
Loading...